双鹭药业参股公司轩竹生物预计于10月15日在联交所挂牌上市

Core Viewpoint - Shuanglu Pharmaceutical's associate company, Xuan Zhu Bio, is expected to officially list on the Hong Kong Stock Exchange on October 15, 2025, with a global offering of 67.335 million shares priced at HKD 11.60 per share [1] Summary by Relevant Sections - Company Holdings - Shuanglu Pharmaceutical holds a total of 1.7808 million shares in Xuan Zhu Bio, which is expected to represent 0.34% of the total shares post-issuance [1] - Lock-up Period - The lock-up period for Shuanglu Pharmaceutical's shares in Xuan Zhu Bio will last for 12 months following the company's listing [1]